{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T22:10:11Z","timestamp":1714515011102},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00066-012-0216-y","type":"journal-article","created":{"date-parts":[[2012,10,30]],"date-time":"2012-10-30T08:20:05Z","timestamp":1351585205000},"page":"1139-1145","source":"Crossref","is-referenced-by-count":4,"title":["Plasminogen activator inhibitor-1 (PAI-1) expression in relation to hypoxia and oncoproteins in clinical cervical tumors","Rolle der Expression von Plasminogenaktivatorinhibitor\u00a01 (PAI-1) in Bezug auf Hypoxie und Onkoproteine beim Zervixkarzinom"],"prefix":"10.1007","volume":"188","author":[{"given":"P.C.","family":"Lara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lloret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Valenciano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Clavo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Pinar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. A.","family":"Henr\u00edquez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,1]]},"reference":[{"key":"216_CR1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1095\/biolreprod48.2.287","volume":"48","author":"Carnegie","year":"1993","unstructured":"Carnegie JA, Cabaca O (1993) Extracellular matrix composition and resilience: two parameters that influence the in vitro migration and morphology of rat inner cell mass-derived cells. Biol Reprod 48:287\u2013299","journal-title":"Biol Reprod"},{"key":"216_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bdrc.20002","volume":"72","author":"Kadler","year":"2004","unstructured":"Kadler K (2004) Matrix loading: assembly of extracellular matrix collagen fibrils during embryogenesis. Birth Defects Res C Embryo Today 72:1\u201311","journal-title":"Birth Defects Res C Embryo Today"},{"key":"216_CR3","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/dvdy.20217","volume":"231","author":"Davidson","year":"2004","unstructured":"Davidson LA, Keller R, DeSimone DW (2004) Assembly and remodeling of the fibrillar fibronectin extracellular matrix during gastrulation and neurulation in Xenopus laevis. Dev Dyn 231:888\u2013895","journal-title":"Dev Dyn"},{"key":"216_CR4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1359\/jbmr.2002.17.2.275","volume":"17","author":"Mwale","year":"2002","unstructured":"Mwale F, Tchetina E, Wu CW, Poole AR (2002) The assembly and remodeling of the extracellular matrix in the growth plate in relationship to mineral deposition and cellular hypertrophy: an in situ study of collagens II and IX and proteoglycan. J Bone Miner Res 17:275\u2013283","journal-title":"J Bone Miner Res"},{"key":"216_CR5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-0038-1642655","volume":"74","author":"Wiman","year":"1995","unstructured":"Wiman B (1995) Plasminogen activator inhibitor 1 (PAI-1) in plasma: its role in thrombotic disease. Thromb Haemost 74:71\u201376","journal-title":"Thromb Haemost"},{"key":"216_CR6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1055\/s-0038-1660104","volume":"54","author":"Paramo","year":"1985","unstructured":"Paramo JA, Alfaro MJ, Rocha E (1985) Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor\u2014relationship to deep vein thrombosis and influence of prophylaxis. Thromb Haemost 54:713\u2013716","journal-title":"Thromb Haemost"},{"key":"216_CR7","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0006-2952(03)00162-X","volume":"65","author":"Goto","year":"2003","unstructured":"Goto D, Fujii S, Kaneko T et al (2003) Intracellular signal transduction modulating expression of plasminogen activator inhibitor-1 in adipocytes. Biochem Pharmacol 65:1907\u20131914","journal-title":"Biochem Pharmacol"},{"key":"216_CR8","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/aje\/152.10.897","volume":"152","author":"Sakkinen","year":"2000","unstructured":"Sakkinen PA, Wahl P, Cushman M et al (2000) Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 152:897\u2013907","journal-title":"Am J Epidemiol"},{"key":"216_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399402004362","volume":"4","author":"Bodary","year":"2002","unstructured":"Bodary PF, Wickenheiser KJ, Eitzman DT (2002) Recent advances in understanding endogenous fibrinolysis: implications for molecular-based treatment of vascular disorders. Expert Rev Mol Med 4:1\u201310","journal-title":"Expert Rev Mol Med"},{"key":"216_CR10","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1158\/1055-9965.EPI-06-0351","volume":"15","author":"Sternlicht","year":"2006","unstructured":"Sternlicht MD, Dunning AM, Moore DH et al (2006) Prognostic value of PAI1 in invasive breast cancer: evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression. Cancer Epidemiol Biomarkers Prev 15:2107\u20132114","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"216_CR11","first-page":"61","volume":"29","author":"Jankun","year":"2012","unstructured":"Jankun J, Yang J, Zheng H et al (2012) Remarkable extension of PAI-1 half-life surprisingly brings no changes to its structure. Int J Mol Med 29:61\u201364","journal-title":"Int J Mol Med"},{"key":"216_CR12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jso.21611","volume":"102","author":"Markl","year":"2010","unstructured":"Markl B, Renk I, Oruzio DV et al (2010) Tumour budding, uPA and PAI-1 are associated with aggressive behaviour in colon cancer. J Surg Oncol 102:235\u2013241","journal-title":"J Surg Oncol"},{"key":"216_CR13","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.2174\/092986710793361216","volume":"17","author":"Malinowsky","year":"2010","unstructured":"Malinowsky K, Bollner C, Hipp S et al (2010) UPA and PAI-1 analysis from fixed tissues\u2014new perspectives for a known set of predictive markers. Curr Med Chem 17:4370\u20134377","journal-title":"Curr Med Chem"},{"key":"216_CR14","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1242\/jcs.115.15.3093","volume":"115","author":"Samarakoon","year":"2002","unstructured":"Samarakoon R, Higgins PJ (2002) MEK\/ERK pathway mediates cell-shape-dependent plasminogen activator inhibitor type 1 gene expression upon drug-induced disruption of the microfilament and microtubule networks. J Cell Sci 115:3093\u20133103","journal-title":"J Cell Sci"},{"key":"216_CR15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00441-011-1181-y","volume":"347","author":"Samarakoon","year":"2012","unstructured":"Samarakoon R, Overstreet JM, Higgins SP, Higgins PJ (2012) TGF-beta1 \u2013> SMAD\/p53\/USF2 \u2013>PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis. Cell Tissue Res 347:117\u2013128","journal-title":"Cell Tissue Res"},{"key":"216_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/CCI.S2775","volume":"2","author":"Higgins","year":"2009","unstructured":"Higgins SP, Samarakoon R, Higgins CE et al (2009) TGF-beta1-Induced expression of the anti-apoptotic pai-1 protein requires egfr signaling. Cell Commun Insights 2:1\u201311","journal-title":"Cell Commun Insights"},{"key":"216_CR17","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/ndt\/gfn756","volume":"24","author":"Kimura","year":"2009","unstructured":"Kimura H, Li X, Torii K et al (2009) Dexamethasone enhances basal and TNF-alpha-stimulated production of PAI-1 via the glucocorticoid receptor regardless of 11beta-hydroxysteroid dehydrogenase 2 status in human proximal renal tubular cells. Nephrol Dial Transplant 24:1759\u20131765","journal-title":"Nephrol Dial Transplant"},{"key":"216_CR18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/MCA.0b013e328335790e","volume":"21","author":"Miyagawa","year":"2010","unstructured":"Miyagawa R, Asakura T, Nakamura T et al (2010) Increased expression of plasminogen activator inhibitor type-1 (PAI-1) in HEPG2 cells induced by insulin mediated by the 3\u2019-untranslated region of the PAI-1 gene and its pharmacologic implications. Coron Artery Dis 21:144\u2013150","journal-title":"Coron Artery Dis"},{"key":"216_CR19","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/hr.2011.137","volume":"34","author":"Fogari","year":"2011","unstructured":"Fogari R, Zoppi A, Mugellini A et al (2011) Role of angiotensin II in plasma PAI-1 changes induced by imidapril or candesartan in hypertensive patients with metabolic syndrome. Hypertens Res 34:1321\u20131326","journal-title":"Hypertens Res"},{"key":"216_CR20","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.mehy.2004.03.038","volume":"64","author":"McCarty","year":"2005","unstructured":"McCarty MF (2005) De novo synthesis of diacylglycerol in endothelium may mediate the association between PAI-1 and the insulin resistance syndrome. Med Hypotheses 64:388\u2013393","journal-title":"Med Hypotheses"},{"key":"216_CR21","first-page":"1627","volume":"37","author":"Ahn","year":"2010","unstructured":"Ahn YT, Chua MS, Whitlock JP Jr et al (2010) Rodent-specific hypoxia response elements enhance PAI-1 expression through HIF-1 or HIF-2 in mouse hepatoma cells. Int J Oncol 37:1627\u20131638","journal-title":"Int J Oncol"},{"key":"216_CR22","first-page":"1259","volume":"17","author":"Sprague","year":"2007","unstructured":"Sprague LD, Tomaso H, Mengele K et al (2007) Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells. Oncol Rep 17:1259\u20131268","journal-title":"Oncol Rep"},{"key":"216_CR23","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1080\/02841860801958295","volume":"47","author":"Offersen","year":"2008","unstructured":"Offersen BV, Alsner J, Ege Olsen K et al (2008) A comparison among HER2, TP53, PAI-1, angiogenesis, and proliferation activity as prognostic variables in tumours from 408 patients diagnosed with early breast cancer. Acta Oncol 47:618\u2013632","journal-title":"Acta Oncol"},{"key":"216_CR24","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1074\/jbc.M707539200","volume":"283","author":"Bednarek","year":"2008","unstructured":"Bednarek R, Boncela J, Smolarczyk K et al (2008) Ku80 as a novel receptor for thymosin beta4 that mediates its intracellular activity different from G-actin sequestering. J Biol Chem 283:1534\u20131544","journal-title":"J Biol Chem"},{"key":"216_CR25","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/gcc.20762","volume":"49","author":"Gao","year":"2010","unstructured":"Gao S, Nielsen BS, Krogdahl A et al (2010) Epigenetic alterations of the SERPINE1 gene in oral squamous cell carcinomas and normal oral mucosa. Genes Chromosomes Cancer 49:526\u2013538","journal-title":"Genes Chromosomes Cancer"},{"key":"216_CR26","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0959-8049(97)10038-7","volume":"34","author":"Daneri-Navarro","year":"1998","unstructured":"Daneri-Navarro A, Macias-Lopez G, Oceguera-Villanueva A et al (1998) Urokinase-type plasminogen activator and plasminogen activator inhibitors (PAI-1 and PAI-2) in extracts of invasive cervical carcinoma and precursor lesions. Eur J Cancer 34:566\u2013569","journal-title":"Eur J Cancer"},{"key":"216_CR27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.0004-8666.2002.00385.x","volume":"42","author":"Horn","year":"2002","unstructured":"Horn LC, Pippig S, Raptis G et al (2002) Clinical relevance of urokinase-type plasminogen activator and its inhibitor type 1 (PAI-1) in squamous cell carcinoma of the uterine cervix. Aust N Z J Obstet Gynaecol 42:383\u2013386","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"216_CR28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/(SICI)1096-9896(199910)189:2<245::AID-PATH427>3.0.CO;2-Z","volume":"189","author":"Riethdorf","year":"1999","unstructured":"Riethdorf L, Riethdorf S, Petersen S et al (1999)Urokinase gene expression indicates early invasive growth in squamous cell lesions of the uterine cervix. J Pathol 189:245\u2013250","journal-title":"J Pathol"},{"key":"216_CR29","first-page":"6539","volume":"54","author":"Kobayashi","year":"1994","unstructured":"Kobayashi H, Fujishiro S, Terao T (1994) Impact of urokinase-type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus. Cancer Res 54:6539\u20136548","journal-title":"Cancer Res"},{"key":"216_CR30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0167-8140(02)00391-2","volume":"66","author":"Clavo","year":"2003","unstructured":"Clavo B, Perez JL, Lopez L et al (2003) Influence of haemoglobin concentration and peripheral muscle pO2 on tumour oxygenation in advanced head and neck tumours. Radiother Oncol 66:71\u201374","journal-title":"Radiother Oncol"},{"key":"216_CR31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.radonc.2008.07.018","volume":"89","author":"Lara","year":"2008","unstructured":"Lara PC, Lloret M, Clavo B et al (2008) Hypoxia downregulates Ku70\/80 expression in cervical carcinoma tumors. Radiother Oncol 89:222\u2013226","journal-title":"Radiother Oncol"},{"key":"216_CR32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1748-717X-4-29","volume":"4","author":"Lara","year":"2009","unstructured":"Lara PC, Lloret M, Clavo B et al (2009) Severe hypoxia induces chemo-resistance in clinical cervical tumors through MVP over-expression. Radiat Oncol 4:29","journal-title":"Radiat Oncol"},{"key":"216_CR33","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/ijc.20512","volume":"112","author":"Hazelbag","year":"2004","unstructured":"Hazelbag S, Kenter GG, Gorter A, Fleuren GJ (2004) Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer. Int J Cancer 112:1020\u20131028","journal-title":"Int J Cancer"},{"key":"216_CR34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.radonc.2010.04.002","volume":"97","author":"Niemantsverdriet","year":"2010","unstructured":"Niemantsverdriet M, Jong E de, Langendijk JA et al (2010) Synergistic induction of profibrotic PAI-1 by TGF-beta and radiation depends on p53. Radiother Oncol 97:33\u201335","journal-title":"Radiother Oncol"},{"key":"216_CR35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.radonc.2007.11.011","volume":"86","author":"Bayer","year":"2008","unstructured":"Bayer C, Schilling D, Hoetzel J et al (2008) PAI-1 levels predict response to fractionated irradiation in 10 human squamous cell carcinoma lines of the head and neck. Radiother Oncol 86:361\u2013368","journal-title":"Radiother Oncol"},{"key":"216_CR36","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1158\/1078-0432.CCR-05-0427","volume":"11","author":"Hageman","year":"2005","unstructured":"Hageman J, Eggen BJ, Rozema T et al (2005) Radiation and transforming growth factor-beta cooperate in transcriptional activation of the profibrotic plasminogen activator inhibitor-1 gene. Clin Cancer Res 11:5956\u20135964","journal-title":"Clin Cancer Res"},{"key":"216_CR37","doi-asserted-by":"crossref","first-page":"37536","DOI":"10.1074\/jbc.M305135200","volume":"278","author":"Saito","year":"2003","unstructured":"Saito S, Yamaguchi H, Higashimoto Y et al (2003) Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J Biol Chem 278:37536\u201337544","journal-title":"J Biol Chem"},{"key":"216_CR38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrm2395","volume":"9","author":"Riley","year":"2008","unstructured":"Riley T, Sontag E, Chen P, Levine A (2008) Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9:402\u2013412","journal-title":"Nat Rev Mol Cell Biol"},{"key":"216_CR39","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.ijrobp.2011.09.057","volume":"83","author":"Niemantsverdriet","year":"2012","unstructured":"Niemantsverdriet M, Goethem MJ van, Bron R et al (2012) High and Low LET Radiation Differentially Induce Normal Tissue Damage Signals. Int J Radiat Oncol Biol Phys 83:1291\u20131297","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"216_CR40","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/(SICI)1097-0215(19991008)83:2<247::AID-IJC17>3.0.CO;2-0","volume":"83","author":"Kornmann","year":"1999","unstructured":"Kornmann M, Tangvoranuntakul P, Korc M (1999) TGF-beta-1 up-regulates cyclin D1 expression in COLO-357 cells, whereas suppression of cyclin D1 levels is associated with down-regulation of the type I TGF-beta receptor. Int J Cancer 83:247\u2013254","journal-title":"Int J Cancer"},{"key":"216_CR41","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ijrobp.2008.11.013","volume":"73","author":"Lloret","year":"2009","unstructured":"Lloret M, Lara PC, Bordon E et al (2009) Major vault protein may affect nonhomologous end-joining repair and apoptosis through Ku70\/80 and bax downregulation in cervical carcinoma tumors. Int J Radiat Oncol Biol Phys 73:976\u2013979","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"216_CR42","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1073\/pnas.0706700105","volume":"105","author":"Amsel","year":"2008","unstructured":"Amsel AD, Rathaus M, Kronman N, Cohen HY (2008) Regulation of the proapoptotic factor Bax by Ku70-dependent deubiquitylation. Proc Natl Acad Sci U S A 105:5117\u20135122","journal-title":"Proc Natl Acad Sci U S A"},{"key":"216_CR43","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1160\/TH08-04-0259","volume":"100","author":"Soeda","year":"2008","unstructured":"Soeda S, Koyanagi S, Kuramoto Y et al (2008) Anti-apoptotic roles of plasminogen activator inhibitor-1 as a neurotrophic factor in the central nervous system. Thromb Haemost 100:1014\u20131020","journal-title":"Thromb Haemost"},{"key":"216_CR44","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0167-8140(93)90025-4","volume":"26","author":"Hockel","year":"1993","unstructured":"Hockel M, Knoop C, Schlenger K et al (1993) Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 26:45\u201350","journal-title":"Radiother Oncol"},{"key":"216_CR45","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00066-011-0051-6","volume":"188","author":"Schilling","year":"2012","unstructured":"Schilling D, Bayer C, Emmerich K et al (2012) Basal HIF-1alpha expression levels are not predictive for radiosensitivity of human cancer cell lines. Strahlenther Onkol 188:353\u2013358","journal-title":"Strahlenther Onkol"},{"key":"216_CR46","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00066-011-2210-1","volume":"187","author":"Zips","year":"2011","unstructured":"Zips D, Boke S, Kroeber T et al (2011) Prognostic value of radiobiological hypoxia during fractionated irradiation for local tumor control. Strahlenther Onkol 187:306\u2013310","journal-title":"Strahlenther Onkol"},{"key":"216_CR47","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00066-010-2216-0","volume":"187","author":"Maftei","year":"2011","unstructured":"Maftei CA, Bayer C, Shi K et al (2011) Quantitative assessment of hypoxia subtypes in microcirculatory supply units of malignant tumors using (immuno-) fluorescence techniques. Strahlenther Onkol 187:260\u2013266","journal-title":"Strahlenther Onkol"},{"key":"216_CR48","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0167-8140(98)00044-9","volume":"48","author":"Fyles","year":"1998","unstructured":"Fyles AW, Milosevic M, Wong R et al (1998) Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 48:149\u2013156","journal-title":"Radiother Oncol"},{"key":"216_CR49","first-page":"4509","volume":"56","author":"Hockel","year":"1996","unstructured":"Hockel M, Schlenger K, Aral B et al (1996) Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56:4509\u20134515","journal-title":"Cancer Res"},{"key":"216_CR50","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1158\/0008-5472.CAN-07-6339","volume":"68","author":"Mayer","year":"2008","unstructured":"Mayer A, Hockel M, Wree A et al (2008) Lack of hypoxic response in uterine leiomyomas despite severe tissue hypoxia. Cancer Res 68:4719\u20134726","journal-title":"Cancer Res"},{"key":"216_CR51","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00066-006-1525-9","volume":"182","author":"Mayer","year":"2006","unstructured":"Mayer A, Hockel M, Vaupel P (2006) Endogenous hypoxia markers in locally advanced cancers of the uterine cervix: reality or wishful thinking? Strahlenther Onkol 182:501\u2013510","journal-title":"Strahlenther Onkol"},{"key":"216_CR52","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-0-387-74911-2_15","volume":"614","author":"Mayer","year":"2008","unstructured":"Mayer A, Hockel M, Vaupel P (2008) Endogenous hypoxia markers: case not proven! Adv Exp Med Biol 614:127\u2013136","journal-title":"Adv Exp Med Biol"},{"key":"216_CR53","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","volume":"26","author":"Vaupel","year":"2007","unstructured":"Vaupel P, Mayer A (2007) Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26:225\u2013239","journal-title":"Cancer Metastasis Rev"},{"key":"216_CR54","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1182\/blood.V94.12.4177","volume":"94","author":"Kietzmann","year":"1999","unstructured":"Kietzmann T, Roth U, Jungermann K (1999) Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes. Blood 94:4177\u20134185","journal-title":"Blood"},{"key":"216_CR55","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1172\/JCI307","volume":"102","author":"Pinsky","year":"1998","unstructured":"Pinsky DJ, Liao H, Lawson CA et al (1998) Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition. J Clin Invest 102:919\u2013928","journal-title":"J Clin Invest"},{"key":"216_CR56","doi-asserted-by":"crossref","first-page":"L740","DOI":"10.1152\/ajplung.00146.2010","volume":"300","author":"Ueno","year":"2011","unstructured":"Ueno M, Maeno T, Nomura M et al (2011) Hypoxia-inducible factor-1alpha mediates TGF-beta-induced PAI-1 production in alveolar macrophages in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 300:L740\u2013L752","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"216_CR57","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1182\/blood.V99.6.2077","volume":"99","author":"Fink","year":"2002","unstructured":"Fink T, Kazlauskas A, Poellinger L et al (2002) Identification of a tightly regulated hypoxia-response element in the promoter of human plasminogen activator inhibitor-1. Blood 99:2077\u20132083","journal-title":"Blood"},{"key":"216_CR58","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/excr.1998.4240","volume":"245","author":"Fitzpatrick","year":"1998","unstructured":"Fitzpatrick TE, Graham CH (1998) Stimulation of plasminogen activator inhibitor-1 expression in immortalized human trophoblast cells cultured under low levels of oxygen. Exp Cell Res 245:155\u2013162","journal-title":"Exp Cell Res"},{"key":"216_CR59","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1620\/tjem.196.259","volume":"196","author":"Kimura","year":"2002","unstructured":"Kimura D, Imaizumi T, Tamo W et al (2002) Hypoxia enhances the expression of plasminogen activator inhibitor-1 in human lung cancer cells, EBC-1. Tohoku J Exp Med 196:259\u2013267","journal-title":"Tohoku J Exp Med"},{"key":"216_CR60","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1523-1755.2005.00435.x","volume":"68","author":"Li","year":"2005","unstructured":"Li X, Kimura H, Hirota K et al (2005) Synergistic effect of hypoxia and TNF-alpha on production of PAI-1 in human proximal renal tubular cells. Kidney Int 68:569\u2013583","journal-title":"Kidney Int"},{"key":"216_CR61","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000106789","volume":"71","author":"Sprague","year":"2006","unstructured":"Sprague LD, Mengele K, Schilling D et al (2006) Effect of reoxygenation on the hypoxia-induced up-regulation of serine protease inhibitor PAI-1 in head and neck cancer cells. Oncology 71:282\u2013291","journal-title":"Oncology"},{"key":"216_CR62","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00066-010-2095-4","volume":"186","author":"Nieder","year":"2010","unstructured":"Nieder C, Haukland E, Pawinski A, Dalhaug A (2010) Validation of new prognostic and predictive scores by sequential testing approach. Strahlenther Onkol 186:169\u2013173","journal-title":"Strahlenther Onkol"},{"key":"216_CR63","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s00066-011-2167-0","volume":"187","author":"Staab","year":"2011","unstructured":"Staab A, Fleischer M, Loeffler J et al (2011) Small interfering RNA targeting HIF-1alpha reduces hypoxia-dependent transcription and radiosensitizes hypoxic HT 1080 human fibrosarcoma cells in vitro. Strahlenther Onkol 187:252\u2013259","journal-title":"Strahlenther Onkol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-012-0216-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-012-0216-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-012-0216-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T21:49:58Z","timestamp":1714513798000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-012-0216-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,1]]},"references-count":63,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["216"],"URL":"https:\/\/doi.org\/10.1007\/s00066-012-0216-y","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,1]]}}}